Laboratoire Aguettant SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Laboratoire Aguettant SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011892
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratoire Aguettant (Aguettant) is a pharmaceutical company that offers development, manufacturing and commercialisation of essential hospital medicines. The company offers products under various categories such as specialist sectors and delivery systems. Its speciality sector offers emergency drugs, neurology, nutrition and solutions for infusion, irrigation and urology, rinsing and care, among others. Aguettant also develops new formulation the fields of emergency drugs, the treatment of Parkinson’s disease and nutrition. The company’s products are used in emergency use, micronutrients, neurology and other biotechnology applications. It operates in the UK, Belgium and Vietnam. Aguettant is headquartered in Lyon, France.

Laboratoire Aguettant SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Laboratoire Aguettant to Acquire Commercialization Right of Monover in France 10
Licensing Agreements 11
Baxter International Enters into Agreement with Laboratoire Aguettant 11
PX’Therapeutics Enters Into Licensing Agreement With ribOvax Biotechnologies 12
Acquisition 13
Aguettant Acquires Majority Stake In PX’Therapeutics 13
Laboratoire Aguettant SA – Key Competitors 14
Laboratoire Aguettant SA – Key Employees 15
Laboratoire Aguettant SA – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Key Facts 2
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratoire Aguettant SA, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratoire Aguettant SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Laboratoire Aguettant to Acquire Commercialization Right of Monover in France 10
Baxter International Enters into Agreement with Laboratoire Aguettant 11
PX’Therapeutics Enters Into Licensing Agreement With ribOvax Biotechnologies 12
Aguettant Acquires Majority Stake In PX'Therapeutics 13
Laboratoire Aguettant SA, Key Competitors 14
Laboratoire Aguettant SA, Key Employees 15
Laboratoire Aguettant SA, Subsidiaries 16

★海外企業調査レポート[Laboratoire Aguettant SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asn Bank
    Asn Bank - Strategy, SWOT and Corporate Finance Report Summary Asn Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Southern Company Gas:電力:M&Aディール及び事業提携情報
    Summary Southern Company Gas (SCG), formerly AGL Resources Inc., is an energy services holding company It operates through natural gas distribution, retail operations, wholesale services and midstream. The company serves utility customers through its regulated distribution subsidiaries in the states …
  • Continental Grain Company:企業の戦略・SWOT・財務分析
    Continental Grain Company - Strategy, SWOT and Corporate Finance Report Summary Continental Grain Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Children’s Medical Center:企業の戦略的SWOT分析
    Children's Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • OJSC Rosneft Oil Company:企業の戦略・SWOT・財務分析
    OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report Summary OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nezavisni operator sustava u Bosni i Hercegovini:企業の戦略的SWOT分析
    Nezavisni operator sustava u Bosni i Hercegovini - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Frequency Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Frequency Therapeutics Inc (Frequency Therapeutics) is a biotechnology company that develops progenitor cell activation (PCA) therapies. The company’s small molecule drugs are used to activate progenitor cells for restoration of healthy tissue. Its lead program FX-322 is used to recreate sen …
  • Lansdowne Oil & Gas plc (LOGP):企業の財務・戦略的SWOT分析
    Summary Lansdowne Oil & Gas Plc (Lansdowne Oil & Gas) is an independent oil and gas exploration and production company. The company acquires, explores and develops crude oil and natural gas appraisals in the North Celtic Sea Basin offshore in southern Ireland. It develops Barryroe Field in the North …
  • Sanofi SA:企業の戦略・SWOT・財務情報
    Sanofi SA - Strategy, SWOT and Corporate Finance Report Summary Sanofi SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Standard Chartered Bank Kenya Ltd:企業の戦略・SWOT・財務分析
    Standard Chartered Bank Kenya Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chartered Bank Kenya Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Raschig GmbH:企業の戦略的SWOT分析
    Raschig GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Aston Martin Lagonda Global Holdings plc (AML):企業の財務・戦略的SWOT分析
    Aston Martin Lagonda Global Holdings plc (AML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Luzhou Bio-chem Technology Limited:企業の戦略・SWOT・財務分析
    Luzhou Bio-chem Technology Limited - Strategy, SWOT and Corporate Finance Report Summary Luzhou Bio-chem Technology Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Saudi Pharmaceutical Industries & Medical Appliances Corp (2070):製薬・医療:M&Aディール及び事業提携情報
    Summary Saudi Pharmaceutical Industries & Medical Appliances Corp (SPIMACO) develops, manufactures, and sells pharmaceutical products and medical appliances. The company offers its products in anti-infectives, cardio-vascular, diabetes, GIT, iron supplement, men health, musculoskeletal, pschychatric …
  • First Republic Private Wealth Management:企業の戦略・SWOT・財務情報
    First Republic Private Wealth Management - Strategy, SWOT and Corporate Finance Report Summary First Republic Private Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Banque Internationale à Luxembourg SA:企業の戦略・SWOT・財務情報
    Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report Summary Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Yara International ASA:企業の戦略・SWOT・財務分析
    Yara International ASA - Strategy, SWOT and Corporate Finance Report Summary Yara International ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cracker Barrel Old Country Store, Inc.:企業の戦略・SWOT・財務分析
    Cracker Barrel Old Country Store, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cracker Barrel Old Country Store, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Astron Corp Ltd (ATR):企業の財務・戦略的SWOT分析
    Astron Corp Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sampo plc:企業のM&A・事業提携・投資動向
    Sampo plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sampo plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆